2001
DOI: 10.1097/00000372-200104000-00006
|View full text |Cite
|
Sign up to set email alerts
|

Benign Cutaneous Degos' Disease

Abstract: The following case report details a 53-year-old man with a 6-year history of the benign cutaneous or skin-limited form of Degos' disease. Clinically, the patient demonstrated a diffuse eruption of papules on the upper trunk and arms. Many papules demonstrated the classic porcelain-white centers characteristic of Degos' disease, but others exhibited different clinical morphologies that corresponded to the evolutionary stages of papules originally described by Degos. Over the course of several clinic visits, the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
0

Year Published

2003
2003
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(15 citation statements)
references
References 31 publications
1
14
0
Order By: Relevance
“…In conclusion, atrophic papulosis is a rare disease with a severe and potentially life-threatening systemic form. In contrast, the cutaneous form is remarkably benign, a fact that confirms the findings of other authors 10,[13][14][15] and indicates that the previously so-called 'malignant atrophic papulosis' should be renamed 'atrophic papulosis' and classified into a malignant systemic disease (malignant atrophic papulosis) and a benign cutaneous disease (benign atrophic papulosis). Patients should be worked up and followed in specialized centres following a standard plan ( Table 3).…”
Section: Discussionsupporting
confidence: 85%
“…In conclusion, atrophic papulosis is a rare disease with a severe and potentially life-threatening systemic form. In contrast, the cutaneous form is remarkably benign, a fact that confirms the findings of other authors 10,[13][14][15] and indicates that the previously so-called 'malignant atrophic papulosis' should be renamed 'atrophic papulosis' and classified into a malignant systemic disease (malignant atrophic papulosis) and a benign cutaneous disease (benign atrophic papulosis). Patients should be worked up and followed in specialized centres following a standard plan ( Table 3).…”
Section: Discussionsupporting
confidence: 85%
“…It seems that familial cases may have a better prognosis 2 . Nevertheless, approximately 15% of Degos' disease cases exhibit long‐term survival with disease often limited to the skin and with no history of systemic involvement 9 . To emphasize this clinical picture, some authors have advocated the term benign cutaneous Degos' disease 10 .…”
Section: Reportmentioning
confidence: 99%
“…2 Nevertheless, approximately 15% of Degos' disease cases exhibit long-term survival with disease often limited to the skin and with no history of systemic involvement. 9 To emphasize this clinical picture, some authors have advocated the term benign cutaneous Degos' disease. 10 As yet, there are no means by which one can predict which patients will or will not develop visceral involvement.…”
Section: Reportmentioning
confidence: 99%
“…However, these characteristic features cannot be demonstrated in all cases [25]. Harvell et al [26] examined in a case report the histology of the lesions according to the duration of their existence. Early lesions have shown a superficial and deep perivascular lymphocytic infiltration, with distinct mucin deposition, which resembled lupus erythematosus.…”
Section: Introductionmentioning
confidence: 99%